Barclays Cuts Chemring Group (LON:CHG) Price Target to GBX 338

Chemring Group (LON:CHG) had its price target cut by analysts at Barclays from GBX 345 ($4.33) to GBX 338 ($4.25) in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The firm presently has an “underweight” rating on the stock. Barclays‘s target price points to a potential downside of 12.66% from the stock’s previous close.

Separately, Shore Capital restated a “buy” rating on shares of Chemring Group in a report on Friday, February 23rd.

Chemring Group Stock Performance

Shares of CHG stock opened at GBX 387 ($4.86) on Tuesday. The firm’s 50 day moving average price is GBX 360.51 and its 200-day moving average price is GBX 341.45. The company has a debt-to-equity ratio of 5.49, a quick ratio of 0.71 and a current ratio of 1.29. Chemring Group has a one year low of GBX 253.95 ($3.19) and a one year high of GBX 412.14 ($5.18). The firm has a market cap of £1.06 billion, a P/E ratio of 2,976.92, a P/E/G ratio of 1.99 and a beta of 0.70.

Insider Buying and Selling

In related news, insider Michael Ord sold 138,209 shares of the company’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of GBX 358 ($4.50), for a total transaction of £494,788.22 ($621,593.24). 1.77% of the stock is owned by insiders.

Chemring Group Company Profile

Chemring Group PLC provides countermeasures, sensors, information, and energetic products in the United States, the United Kingdom, Europe, the Asia pacific, and internationally. The company offers sensors and information products, such as point chemical detector, sensor, JSLSCAD, and I-SCAD; miniature radar altimeter, R Visor, 3D radars, husky mounted detection system, groundshark, MDS-10, and groundhunters; resolve, locate, LOCATE-T, and viper products; and advisory, research, and design and engineering services.